Perspective Total Assets from 2010 to 2024

CATX Stock

4.12 0.28 6.36%

Perspective Therapeutics Total Assets yearly trend continues to be fairly stable with very little volatility. Total Assets are likely to outpace its year average in 2024. Total Assets is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. View All Fundamentals

Total Assets

First Reported

1999-09-30

Previous Quarter

385.9 M

Current Value

391.2 M

Quarterly Volatility

64.2 M

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Check Perspective Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Perspective Therapeutics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 1 M, Total Revenue of 1.4 M or Gross Profit of 1.3 M, as well as many indicators such as Price To Sales Ratio of 55.63, Dividend Yield of 0.0 or PTB Ratio of 1.36. Perspective financial statements analysis is a perfect complement when working with Perspective Therapeutics Valuation or Volatility modules.

Check out the analysis of Perspective Therapeutics Correlation against competitors.

For more information on how to buy Perspective Stock please use our How to Invest in Perspective Therapeutics guide.

Latest Perspective Therapeutics' Total Assets Growth Pattern

Below is the plot of the Total Assets of Perspective Therapeutics over the last few years. Total assets refers to the total amount of Perspective Therapeutics assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Perspective Therapeutics books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. Perspective Therapeutics' Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Perspective Therapeutics' overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 97.89 M

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Total Assets

Timeline

Perspective Total Assets Regression Statistics

	Arithmetic Mean	34,466,227
	Geometric Mean	20,104,512
	Coefficient Of Variation	100.71
	Mean Deviation	29,505,522
	Median	18,101,850
	Standard Deviation	34,710,388
	Sample Variance	1204.8T
	Range	99.9M
	R-Value	0.84
	Mean Square Error	391.3T
	R-Squared	0.70
	Significance	0.0001
	Slope	6,486,244
	Total Sum of Squares	16867.4T

Perspective Total Assets History

	2024	102.8 M
	2023	97.9 M
	2022	58.1 M
	2021	64.4 M
	2020	70.4 M
	2019	8.7 M
	2018	9.4 M

Other Fundumenentals of Perspective Therapeutics

Intangibles To Total Assets

Perspective Therapeutics Total Assets component correlations

	Total Assets	Total Stockholder Equity	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Short Term Debt	Common Stock	Good Will	Intangible Assets	Short Term Investments	Net Invested Capital	Capital Stock	Net Working Capital	Net Tangible Assets	Property Plant Equipment	Long Term Debt	Short Long Term Debt
Total Assets		0.99	-0.24	-0.48	-0.87	0.82	0.33	0.81	0.57	-0.34	0.96	0.42	0.77	-0.28	0.89	0.91	0.3	0.91	-0.89	-0.73	-0.73
Total Stockholder Equity	0.99		-0.26	-0.6	-0.84	0.73	0.4	0.71	0.69	-0.22	0.92	0.42	0.67	-0.25	0.92	0.87	0.41	0.94	-0.82	-0.64	-0.64
Current Deferred Revenue	-0.24	-0.26		0.2	0.5	-0.1	-0.53	-0.07	-0.24	-0.49	-0.26	-0.97	-0.08	0.16	-0.17	-0.15	-0.09	-0.18	0.13	0.08	0.08
Net Debt	-0.48	-0.6	0.2		0.26	0.07	-0.58	0.08	-0.93	-0.38	-0.29	-0.15	0.13	0.24	-0.6	-0.19	-0.95	-0.69	0.11	-0.12	-0.12
Retained Earnings	-0.87	-0.84	0.5	0.26		-0.83	-0.44	-0.8	-0.37	0.23	-0.94	-0.68	-0.77	0.4	-0.73	-0.85	-0.07	-0.74	0.85	0.74	0.74
Accounts Payable	0.82	0.73	-0.1	0.07	-0.83		0.01	1.0	0.02	-0.68	0.92	0.35	0.99	-0.31	0.61	0.89	-0.2	0.6	-0.94	-0.94	-0.94
Net Receivables	0.33	0.4	-0.53	-0.58	-0.44	0.01		0.01	0.58	0.39	0.29	0.49	-0.04	-0.27	0.43	0.18	0.54	0.48	-0.09	0.06	0.06
Total Liab	0.81	0.71	-0.07	0.08	-0.8	1.0	0.01		-0.02	-0.71	0.91	0.32	1.0	-0.35	0.58	0.85	-0.19	0.57	-0.92	-0.95	-0.95
Total Current Assets	0.57	0.69	-0.24	-0.93	-0.37	0.02	0.58	-0.02		0.39	0.38	0.21	-0.08	0.01	0.73	0.37	0.78	0.78	-0.23	0.08	0.08
Short Term Debt	-0.34	-0.22	-0.49	-0.38	0.23	-0.68	0.39	-0.71	0.39		-0.44	0.29	-0.73	0.24	-0.22	-0.43	0.36	-0.17	0.5	0.59	0.59
Common Stock	0.96	0.92	-0.26	-0.29	-0.94	0.92	0.29	0.91	0.38	-0.44		0.47	0.88	-0.36	0.82	0.94	0.12	0.82	-0.94	-0.84	-0.84
Good Will	0.42	0.42	-0.97	-0.15	-0.68	0.35	0.49	0.32	0.21	0.29	0.47		0.33	-0.25	0.29	0.35	0.03	0.29	-0.36	-0.33	-0.33
Intangible Assets	0.77	0.67	-0.08	0.13	-0.77	0.99	-0.04	1.0	-0.08	-0.73	0.88	0.33		-0.36	0.53	0.82	-0.23	0.51	-0.9	-0.95	-0.95
Short Term Investments	-0.28	-0.25	0.16	0.24	0.4	-0.31	-0.27	-0.35	0.01	0.24	-0.36	-0.25	-0.36		-0.07	-0.04	-0.36	-0.15	0.21	0.34	0.34
Net Invested Capital	0.89	0.92	-0.17	-0.6	-0.73	0.61	0.43	0.58	0.73	-0.22	0.82	0.29	0.53	-0.07		0.85	0.4	0.99	-0.73	-0.42	-0.42
Capital Stock	0.91	0.87	-0.15	-0.19	-0.85	0.89	0.18	0.85	0.37	-0.43	0.94	0.35	0.82	-0.04	0.85		-0.03	0.82	-0.94	-0.78	-0.78
Net Working Capital	0.3	0.41	-0.09	-0.95	-0.07	-0.2	0.54	-0.19	0.78	0.36	0.12	0.03	-0.23	-0.36	0.4	-0.03		0.51	0.06	0.21	0.21
Net Tangible Assets	0.91	0.94	-0.18	-0.69	-0.74	0.6	0.48	0.57	0.78	-0.17	0.82	0.29	0.51	-0.15	0.99	0.82	0.51		-0.72	-0.44	-0.44
Property Plant Equipment	-0.89	-0.82	0.13	0.11	0.85	-0.94	-0.09	-0.92	-0.23	0.5	-0.94	-0.36	-0.9	0.21	-0.73	-0.94	0.06	-0.72		0.88	0.88
Long Term Debt	-0.73	-0.64	0.08	-0.12	0.74	-0.94	0.06	-0.95	0.08	0.59	-0.84	-0.33	-0.95	0.34	-0.42	-0.78	0.21	-0.44	0.88		1.0
Short Long Term Debt	-0.73	-0.64	0.08	-0.12	0.74	-0.94	0.06	-0.95	0.08	0.59	-0.84	-0.33	-0.95	0.34	-0.42	-0.78	0.21	-0.44	0.88	1.0

Click cells to compare fundamentals

About Perspective Therapeutics Financial Statements

Perspective Therapeutics investors use historical fundamental indicators, such as Perspective Therapeutics' Total Assets, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Perspective Therapeutics. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Total Assets	97.9 M	102.8 M
Intangibles To Total Assets	0.76	0.80

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C

Additional Tools for Perspective Stock Analysis

When running Perspective Therapeutics' price analysis, check to measure Perspective Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Perspective Therapeutics is operating at the current time. Most of Perspective Therapeutics' value examination focuses on studying past and present price action to predict the probability of Perspective Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Perspective Therapeutics' price. Additionally, you may evaluate how the addition of Perspective Therapeutics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC